@article{rialland:hal-03932792,
TITLE = {Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial},
AUTHOR = {Rialland, Fanny and Grain, Audrey and Labopin, Myriam and Michel, Gerard and Gandemer, Virginie and Paillard, Catherine and Pochon, C{\'e}cile and Clement, Laurence and Brissot, Eolia and Jubert, Charlotte and Sirvent, Anne and Rohrlich, Pierre Simon and Plantaz, Dominique and Dalle, Jean-Hugues and Mohty, Mohamad},
URL = {https://univ-rennes.hal.science/hal-03932792},
JOURNAL = {Bone Marrow Transplantation},
PUBLISHER = {Nature Publishing Group},
VOLUME = {57},
NUMBER = {11},
PAGES = {1698-1703},
YEAR = {2022},
MONTH = Nov, DOI = {10.1038/s41409-022-01769-5},
HAL_ID = {hal-03932792},
HAL_VERSION = {v1},
}